受SABR-COMET启发的局部区域治疗试验。 - Suppr | 超能文献

Trials of locoregional therapies inspired by SABR-COMET.

作者信息

Kamarinos Nikiforos Vasiniotis, Dawson Laura A, Saltz Leonard B, Crane Christopher H, Overman Michael J, Vauthey Jean-Nicolas, Odisio Bruno C, Denys Alban, de Baère Thierry, Pereira Philippe L, Sze Daniel Y, Vogl Thomas J, Meijerink Martijn R, Helmberger Thomas, Kim Hyun S, Solomon Stephen B, Sofocleous Constantinos T

机构信息

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Princess Margaret Hospital Cancer Centre, Toronto, Canada.

出版信息

Lancet. 2020 Oct 3;396(10256):956-957. doi: 10.1016/S0140-6736(20)32023-7.

DOI:10.1016/S0140-6736(20)32023-7

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Trials of locoregional therapies inspired by SABR-COMET.受SABR-COMET启发的局部区域治疗试验。

Lancet. 2020 Oct 3;396(10256):956-957. doi: 10.1016/S0140-6736(20)32023-7.

2

Points to consider regarding the SABR-COMET trial.关于SABR-COMET试验的需考虑要点。

Lancet. 2020 Feb 8;395(10222):e19. doi: 10.1016/S0140-6736(19)32494-8.

3

SABR-COMET: harbinger of a new cancer treatment paradigm.立体定向消融放疗-多中心随机对照试验：一种新癌症治疗模式的先驱

Lancet. 2019 May 18;393(10185):2013-2014. doi: 10.1016/S0140-6736(19)30278-8. Epub 2019 Apr 11.

4

SABR improves outcomes.立体定向消融放疗可改善治疗效果。

Nat Rev Clin Oncol. 2019 Jul;16(7):402. doi: 10.1038/s41571-019-0217-1.

5

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.寡转移环境下立体定向消融放疗（SABR）与标准治疗对比的生活质量结局：SABR-COMET 随机试验的二次分析。

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):943-947. doi: 10.1016/j.ijrobp.2019.08.041. Epub 2019 Aug 27.

6

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.立体定向消融放疗治疗 4-10 个寡转移肿瘤的综合治疗（SABR-COMET-10）：一项随机 III 期试验的研究方案。

BMC Cancer. 2019 Aug 19;19(1):816. doi: 10.1186/s12885-019-5977-6.

7

Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.立体定向消融放疗治疗 1-3 处寡转移瘤的综合治疗（SABR-COMET-3）：一项随机 III 期试验的研究方案。

BMC Cancer. 2020 May 5;20(1):380. doi: 10.1186/s12885-020-06876-4.

8

[Relevance of stereotactic ablative radiotherapy in patients with systemic metastasis].[立体定向消融放疗在全身转移患者中的相关性]

Strahlenther Onkol. 2019 Oct;195(10):943-944. doi: 10.1007/s00066-019-01505-x.

9

Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer.超高分割放疗应成为中危前列腺癌的一种标准治疗选择。

Clin Oncol (R Coll Radiol). 2020 Mar;32(3):170-174. doi: 10.1016/j.clon.2019.11.004. Epub 2019 Nov 28.

10

Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.立体定向体部放射治疗不可手术Ⅰ期肺癌：从姑息性治疗到根治性选择。

Swiss Med Wkly. 2013 May 28;143:w13780. doi: 10.4414/smw.2013.13780. eCollection 2013.

引用本文的文献

1

Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours.立体定向体部放射治疗复发性和寡转移性头颈部肿瘤

J Clin Med. 2024 May 21;13(11):3020. doi: 10.3390/jcm13113020.

2

First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac.在一体化磁共振直线加速器上进行立体定向消融放疗治疗淋巴结和肝脏寡转移疾病的首个多中心经验。

Tech Innov Patient Support Radiat Oncol. 2022 May 10;22:50-54. doi: 10.1016/j.tipsro.2022.04.005. eCollection 2022 Jun.

3

Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist.不可切除的结直肠癌转移患者的局部治疗：肿瘤内科医生视角的综述

Cancers (Basel). 2021 Nov 25;13(23):5938. doi: 10.3390/cancers13235938.